We are committed to our vision of transforming patient lives and making EPI01 a global and affordable solution for patients. We have established collaborations with patients and physicians at centers of excellence.
We will continue to collaborate, learn and leverage our clinical expertise to further advance our development pipeline.
We are looking for exceptional individuals who share our passion for great science and commitment to making a difference in the lives of patients. With our gene control therapy and clinical translational capabilities, we have built a clinical stage product platform with broad potential application in severe genetic diseases and immunotherapies for cancer.
Our clinical programs include: a Phase 1/2 study, for the treatment of severe sickle cell disease. We anticipate treating the first patient in our Phase 3/Pivotal study in 2018. We also have ongoing immuno-oncology programs targeting hematological and solid tumors, as well as discovery research programs with gene control technologies.
We are currently welcoming new members who can excel in the following positions as a member of our great team.
Please send your resume and cover letter to: email@example.com